Stories of Technology, Innovation, & Entrepreneurship in the Southeast

Knoxville Business News Tennessee Mountain Scenery Background - Default Cover Image
September 30, 2013 | Tom Ballard

Provectus presents update on PV-10 drug at European Cancer Congress

Knoxville-based Provectus Pharmaceuticals, Inc., presented  detailed findings from the Phase 2 trial of its PV-10 drug yesterday at the “European Cancer Congress 2013” in Amsterdam, The Netherlands. For more information, read the company’s news release.

Like what you've read?

Forward to a friend!

Don’t Miss Out on the Southeast’s Latest Entrepreneurial, Business, & Tech News!

Sign-up to get the Teknovation Newsletter in your inbox each morning!

  • This field is for validation purposes and should be left unchanged.

No, thanks!